1
|
Halai P, Kiss O, Wang R, Chien AL, Kang S, O'Connor C, Bell M, Griffiths CEM, Watson REB, Langton AK. Retinoids in the treatment of photoageing: A histological study of topical retinoid efficacy in black skin. J Eur Acad Dermatol Venereol 2024. [PMID: 38682699 DOI: 10.1111/jdv.20043] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/11/2023] [Accepted: 03/15/2024] [Indexed: 05/01/2024]
Abstract
BACKGROUND Photoageing describes complex cutaneous changes that occur due to chronic exposure to solar ultraviolet radiation (UVR). The 'gold standard' for the treatment of photoaged white skin is all-trans retinoic acid (ATRA); however, cosmetic retinol (ROL) has also proven efficacious. Recent work has identified that black skin is susceptible to photoageing, characterized by disintegration of fibrillin-rich microfibrils (FRMs) at the dermal-epidermal junction (DEJ). However, the impact of topical retinoids for repair of black skin has not been well investigated. OBJECTIVES To determine the potential of retinoids to repair photoaged black skin. METHODS An exploratory intervention study was performed using an in vivo, short-term patch test protocol. Healthy but photoaged black volunteers (>45 years) were recruited to the study, and participant extensor forearms were occluded with either 0.025% ATRA (n = 6; 4-day application due to irritancy) or ROL (12-day treatment protocol for a cosmetic) at concentrations of 0.3% (n = 6) or 1% (n = 6). Punch biopsies from occluded but untreated control sites and retinoid-treated sites were processed for histological analyses of epidermal characteristics, melanin distribution and dermal remodelling. RESULTS Treatment with ATRA and ROL induced significant acanthosis (all p < 0.001) accompanied by a significant increase in keratinocyte proliferation (Ki67; all p < 0.01), dispersal of epidermal melanin and restoration of the FRMs at the DEJ (all p < 0.01), compared to untreated control. CONCLUSIONS This study confirms that topical ATRA has utility for the repair of photoaged black skin and that ROL induces comparable effects on epidermal and dermal remodelling, albeit over a longer timeframe. The effects of topical retinoids on black photoaged skin are similar to those reported for white photoaged skin and suggest conserved biology in relation to repair of UVR-induced damage. Further investigation of topical retinoid efficacy in daily use is warranted for black skin.
Collapse
Affiliation(s)
- P Halai
- Centre for Dermatology Research, The University of Manchester & Salford Royal NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, UK
| | - O Kiss
- Centre for Dermatology Research, The University of Manchester & Salford Royal NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, UK
| | - R Wang
- Department of Dermatology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA
| | - A L Chien
- Department of Dermatology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA
| | - S Kang
- Department of Dermatology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA
| | - C O'Connor
- No7 Beauty Company, Walgreens Boots Alliance, Nottingham, UK
| | - M Bell
- No7 Beauty Company, Walgreens Boots Alliance, Nottingham, UK
| | - C E M Griffiths
- Centre for Dermatology Research, The University of Manchester & Salford Royal NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, UK
- Department of Dermatology, King's College Hospital, King's College London, London, UK
| | - R E B Watson
- Centre for Dermatology Research, The University of Manchester & Salford Royal NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, UK
- A*STAR Skin Research Laboratory (A*SRL), Agency for Science, Technology and Research (A*STAR), Singapore, Singapore
| | - A K Langton
- Centre for Dermatology Research, The University of Manchester & Salford Royal NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, UK
| |
Collapse
|
2
|
Valadkhani A, Gupta A, Bell M. Perioperative myocardial injury is associated with increased postoperative non-cardiac complications in patients undergoing vascular surgery: a post hoc analysis of a randomised clinical pilot trial. Perioper Med (Lond) 2023; 12:58. [PMID: 37957761 PMCID: PMC10644402 DOI: 10.1186/s13741-023-00350-y] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/19/2023] [Accepted: 11/05/2023] [Indexed: 11/15/2023] Open
Abstract
BACKGROUND Elevated cardiac biomarkers, such as high-sensitivity cardiac Troponin T and N-terminal pro-B-type natriuretic peptide improve the prediction of major adverse cardiac events. However, very few trials have investigated the association between perioperative cardiac injury and non-cardiac complications. The primary aim of this study was to determine the association between peri-operative myocardial injury and non-cardiac complications in patients undergoing vascular surgery. Additionally, the association between elevated pre-operative high-sensitivity cardiac Troponin T or N-terminal pro-B-type natriuretic peptide and non-cardiac complications was explored. METHODS This study is a post hoc analysis of a multicentre randomised controlled trial. Patients were recruited from three centres in Sweden between 2016 and 2019. Cardiac troponin level was measured pre-operatively and at 4, 24, and 48 h after the start of surgery in patients undergoing vascular surgery. N-terminal pro-B-type natriuretic peptide was measured pre-operatively. The primary outcome was a composite of major postoperative non-cardiac complications assessed at 30 days. RESULTS A total of 184 patients undergoing peripheral or aortic vascular surgery were included in this study. The primary endpoint occurred in 67 (36%) patients. Perioperative myocardial injury was significantly associated with non-cardiac complications, with an adjusted odds ratio (OR) of 2.71 (95% confidence interval 1.33-5.55, P = 0.01). Sensitivity and specificity were 0.40 and 0.81, respectively. No association was found between pre-operative hs-cTnT or NT-proBNP and non-cardiac complications. CONCLUSION In this pilot study, we found that new peri-operative myocardial injury is associated with an increased risk of non-cardiac complications within 30 days after index surgery in patients undergoing vascular surgery. Pre-operative high-sensitivity cardiac Troponin T or N-terminal pro-B-type natriuretic peptide did not appear to predict non-cardiac complications. Larger studies are needed to confirm our findings. TRIAL REGISTRATION EudraCT database: 2016-001584-36.
Collapse
Affiliation(s)
- A Valadkhani
- Perioperative Medicine and Intensive Care (PMI), Karolinska University Hospital, Stockholm, Sweden.
- Department of Pharmacology and Physiology, Karolinska Institutet, Stockholm, Sweden.
| | - A Gupta
- Perioperative Medicine and Intensive Care (PMI), Karolinska University Hospital, Stockholm, Sweden
- Department of Pharmacology and Physiology, Karolinska Institutet, Stockholm, Sweden
| | - M Bell
- Perioperative Medicine and Intensive Care (PMI), Karolinska University Hospital, Stockholm, Sweden
- Department of Pharmacology and Physiology, Karolinska Institutet, Stockholm, Sweden
| |
Collapse
|
3
|
Bell M, Lui H, Lee TK, Kalia S. Validation of medical service insurance claims as a surrogate for ascertaining vitiligo cases. Arch Dermatol Res 2023; 315:541-550. [PMID: 36173455 DOI: 10.1007/s00403-022-02383-7] [Citation(s) in RCA: 1] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/23/2022] [Revised: 04/23/2022] [Accepted: 08/02/2022] [Indexed: 11/02/2022]
Abstract
The epidemiology of vitiligo, especially its disease burden on the healthcare system, can be assessed indirectly by analyzing health insurance claims data. Validating this approach is integral to ensuring accurate case identification and cohort characterization. The primary aim of this study was to develop and validate an indirect measure of vitiligo ascertainment using health insurance claims data. These data were used secondarily to identify demographic characteristics, body site involvement, vitiligo subtypes, disease associations, and treatments. This study assessed the validity of identifying vitiligo from billing claims within a Canadian provincial universal health insurance program, versus vitiligo cases accrued from direct medical chart reviews. Claims-based algorithms combining ICD-9-CM diagnostic code 709 with treatment-specific data were derived and tested to identify vitiligo patients. This was compared against cases arising from the manual review of medical records of 606 patient with a diagnostic code for "dyschromia" (ICD-9-CM diagnostic code 709) from January 1 to December 31, 2016. Based on the chart reviews, 204 (33.7%) patients were confirmed to have vitiligo. 42 separate claims-based algorithms combining ICD-9-CM diagnostic code 709 with treatment data specific to vitiligo were modeled and individually tested to evaluate their accuracy for vitiligo ascertainment. One algorithm achieved a sensitivity, specificity, PPV and NPV of 86.8% (95% CI 82.1-91.4), 92.5% (95% CI 90.0-95.1), 85.5% (95% CI 80.7-90.3), and 93.2% (95% CI 90.8-95.7), respectively. There was a 2.2 female-to-male ratio. The most common medical treatments were tacrolimus (74.5%) and topical corticosteroids (54.3%). Hypertension (24.2%) and hypothyroidism (19.6%) were the predominant co-morbidities associated with vitiligo. Health insurance claims data can be used to indirectly ascertain vitiligo for epidemiologic purposes with relatively high diagnostic performance between 85.5 and 93.2%.
Collapse
Affiliation(s)
- M Bell
- Department of Dermatology and Skin Science, University of British Columbia, 835 West 10th Avenue, Vancouver, BC, V5Z 4E8, Canada
- Photomedicine Institute, Vancouver Coastal Health Research Institute, Vancouver, Canada
| | - H Lui
- Department of Dermatology and Skin Science, University of British Columbia, 835 West 10th Avenue, Vancouver, BC, V5Z 4E8, Canada
- Photomedicine Institute, Vancouver Coastal Health Research Institute, Vancouver, Canada
- Department of Cancer Control and/or Integrative Oncology and Imaging, BC Cancer, Vancouver, Canada
| | - T K Lee
- Department of Dermatology and Skin Science, University of British Columbia, 835 West 10th Avenue, Vancouver, BC, V5Z 4E8, Canada
- Photomedicine Institute, Vancouver Coastal Health Research Institute, Vancouver, Canada
- Department of Cancer Control and/or Integrative Oncology and Imaging, BC Cancer, Vancouver, Canada
| | - S Kalia
- Department of Dermatology and Skin Science, University of British Columbia, 835 West 10th Avenue, Vancouver, BC, V5Z 4E8, Canada.
- Photomedicine Institute, Vancouver Coastal Health Research Institute, Vancouver, Canada.
- Department of Cancer Control and/or Integrative Oncology and Imaging, BC Cancer, Vancouver, Canada.
- Centre for Clinical Evaluation and Epidemiology, Vancouver Coastal Health Research Institute, Vancouver, Canada.
- Division of Dermatology, BC Children's Hospital Research Institute, Vancouver, Canada.
| |
Collapse
|
4
|
Banayosy AME, Vanhooser D, Bell M, Horstmanshof D, Cunningham L, Corder M, Maybauer M, Long J, El Banayosy A. Outcomes of Refractory Cardiogenic Shock (CS) Patients Supported by Impella 5.5 as a Bridge to Recovery or Advanced HF Therapies. J Heart Lung Transplant 2023. [DOI: 10.1016/j.healun.2023.02.822] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 04/05/2023] Open
|
5
|
Schwartz G, Lutz D, Bell M, Klug M. 39P Longitudinal increases in albumin-adjusted serum calcium predict ovarian cancer. Ann Oncol 2022. [DOI: 10.1016/j.annonc.2022.04.057] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022] Open
|
6
|
Christie DR, Veloso JAV, Campus P, Bell M, Hoffmann T, Langlois A, Martysevich P, Demirovic E, Carvalho J. Detection of atmospheric nuclear explosions: the infrasound component of the International Monitoring System. KERNTECHNIK 2022. [DOI: 10.1515/kern-2001-0058] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022]
Abstract
Abstract
The infrasound component of the International Monitoring System (IMS') for Comprehensive Nuclear-Test-Ban Treaty verification will consist of 60 array stations distributed as uniformly as possible over the surface of the globe. This network will be far larger and more sensitive than any other previously operated infrasound network. In this paper, we discuss the design and performance characteristics of this monitoring network and the current status of the site survey and installation programs. A brief review of significant developments in infrasound monitoring technology in the last few years is also presented along with a summary of the various areas where data from this unique global network is likely to be of value to the scientific community.
Collapse
Affiliation(s)
- D. R. Christie
- Preparatory Commission for the Comprehensive Nuclear-Test-Ban Treaty Organization, Provisional Technical Secretariat, Vienna International , , A-1400 Vienna , Austria
| | - J. A. Vivas Veloso
- Preparatory Commission for the Comprehensive Nuclear-Test-Ban Treaty Organization, Provisional Technical Secretariat, Vienna International , , A-1400 Vienna , Austria
| | - P Campus
- Preparatory Commission for the Comprehensive Nuclear-Test-Ban Treaty Organization, Provisional Technical Secretariat, Vienna International , , A-1400 Vienna , Austria
| | - M. Bell
- Preparatory Commission for the Comprehensive Nuclear-Test-Ban Treaty Organization, Provisional Technical Secretariat, Vienna International , , A-1400 Vienna , Austria
| | | | - A. Langlois
- Preparatory Commission for the Comprehensive Nuclear-Test-Ban Treaty Organization, Provisional Technical Secretariat, Vienna International , , A-1400 Vienna , Austria
| | - P. Martysevich
- Preparatory Commission for the Comprehensive Nuclear-Test-Ban Treaty Organization, Provisional Technical Secretariat, Vienna International , , A-1400 Vienna , Austria
| | - E. Demirovic
- Preparatory Commission for the Comprehensive Nuclear-Test-Ban Treaty Organization, Provisional Technical Secretariat, Vienna International , , A-1400 Vienna , Austria
| | - J. Carvalho
- Preparatory Commission for the Comprehensive Nuclear-Test-Ban Treaty Organization, Provisional Technical Secretariat, Vienna International , , A-1400 Vienna , Austria
| |
Collapse
|
7
|
Mellody KT, Kendall AC, Wray JR, Foster AR, Langton AK, Costello P, Newton VL, Bell M, Griffiths CEM, Nicolaou A, Watson REB, Pilkington SM. Influence of menopause and hormone replacement therapy on epidermal ageing and skin biomechanical function. J Eur Acad Dermatol Venereol 2022; 36:e576-e580. [PMID: 35279892 PMCID: PMC9314060 DOI: 10.1111/jdv.18071] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
Affiliation(s)
- K T Mellody
- Centre for Dermatology Research Division of Musculoskeletal and Dermatological Sciences School of Biological Sciences The University of Manchester & Salford Royal NHS Foundation Trust Manchester Academic Health Science Centre UK
| | - A C Kendall
- Laboratory for Lipidomics and Lipid Biology Division of Pharmacy and Optometry School of Health Sciences Faculty of Biology Medicine and Health University of Manchester Manchester Academic Health Science Centre Manchester M13 9PL UK
| | - J R Wray
- Laboratory for Lipidomics and Lipid Biology Division of Pharmacy and Optometry School of Health Sciences Faculty of Biology Medicine and Health University of Manchester Manchester Academic Health Science Centre Manchester M13 9PL UK
| | - A R Foster
- Centre for Dermatology Research Division of Musculoskeletal and Dermatological Sciences School of Biological Sciences The University of Manchester & Salford Royal NHS Foundation Trust Manchester Academic Health Science Centre UK
| | - A K Langton
- Centre for Dermatology Research Division of Musculoskeletal and Dermatological Sciences School of Biological Sciences The University of Manchester & Salford Royal NHS Foundation Trust Manchester Academic Health Science Centre UK
| | - P Costello
- Centre for Dermatology Research Division of Musculoskeletal and Dermatological Sciences School of Biological Sciences The University of Manchester & Salford Royal NHS Foundation Trust Manchester Academic Health Science Centre UK
| | - V L Newton
- No7 Beauty Company Walgreens Boots Alliance Nottingham UK
| | - M Bell
- No7 Beauty Company Walgreens Boots Alliance Nottingham UK
| | - C E M Griffiths
- Centre for Dermatology Research Division of Musculoskeletal and Dermatological Sciences School of Biological Sciences The University of Manchester & Salford Royal NHS Foundation Trust Manchester Academic Health Science Centre UK
| | - A Nicolaou
- Laboratory for Lipidomics and Lipid Biology Division of Pharmacy and Optometry School of Health Sciences Faculty of Biology Medicine and Health University of Manchester Manchester Academic Health Science Centre Manchester M13 9PL UK
| | - R E B Watson
- Centre for Dermatology Research Division of Musculoskeletal and Dermatological Sciences School of Biological Sciences The University of Manchester & Salford Royal NHS Foundation Trust Manchester Academic Health Science Centre UK
| | - S M Pilkington
- Centre for Dermatology Research Division of Musculoskeletal and Dermatological Sciences School of Biological Sciences The University of Manchester & Salford Royal NHS Foundation Trust Manchester Academic Health Science Centre UK
| |
Collapse
|
8
|
Hedberg C, Kaler A, Bell M. P110 KNOWLEDGE AND PERCEPTIONS OF ALPHA-GAL SYNDROME AMONG PRIMARY CARE PHYSICIANS IN ARKANSAS 8166. Ann Allergy Asthma Immunol 2021. [DOI: 10.1016/j.anai.2021.08.128] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/19/2022]
|
9
|
Szewc AM, Bell M, Kelly A, Humrighouse B, McQuiston J. Rat-Bite Fever: Developing and testing a modified time-kill protocol based on Edberg and Edberg 1983 experiemnt in order to test S. moniliformis growth in 0.05% SPS and proposed growth curve. Am J Clin Pathol 2021. [DOI: 10.1093/ajcp/aqab191.278] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Abstract
Abstract
Introduction/Objective
Streptobacillus moniliformis is the primary causative agent of rat-bite fever (RBF) and Haverhill fever (HF). Rat-bite fever and Haverhill fever are difficult to diagnose in a clinical setting and are likely severely under-represented and under-reported worldwide. Clinical presentation often includes fever, chills, myalgia, headache, and vomiting. Patients may also develop a maculopapular rash covering their extremities approximately 2-4 days after onset of fever followed by polyarthritis in roughly 50% of patients with a mortality rate of 10-13% if left untreated. This is further complicated by the fact that submission and processing guidelines of clinical samples for the recovery of the organism are based on ‘outdated’ techniques and clinical laboratory methods that are over 50 years removed from current procedures, instrumentation and guidance.
Methods/Case Report
DNA from collected frozen time-point samples, were collected (n=84) and extracted using an in-house custom protocol utilizing 180 µl of bacterial lysis buffer with 20 µl of PCR grade proteinase K, for a total of 200 µl. The blood culture time-point samples were then thawed on ice, and 200 µl of blood culture sample was then added to the lysis mix, vortexed and incubated at 65°C for 10 minutes (an additional 95°C inactivation step was omitted to avoid whole blood clotting). After incubation, each sample was vortexed briefly again and extracted using the Roche automated MagNA Pure Compact instrument with an initial input volume of 400 µl and stored in a final elution buffer volume of 100 µl. All quantatitive time kill data was colleced via a CDC in-house designed PCR assay developed for S. moniliformis.
Results (if a Case Study enter NA)
Experimenting with varying amounts of blood inoculum, 10 ml of blood was determined to provide the best results for detection and growth/viability as well as propose a theoretical growth curve for the organism.
Conclusion
We found that in 100% of the isolates tested (and all the variations of testing within), SPS (up to a concentration of 0.05 % w/v) in commercially available blood culture bottles appeared to be inactivated, allowing for the growth detection and culturing of S. moniliformis using an automated continuous blood culture system when 10 ml of blood was inoculated.
Collapse
Affiliation(s)
- A M Szewc
- Division of High-Consequence Pathogens and Pathology; Bacterial Special Pathogens Branch, Centers for Disease Control and Prevention, Atlanta, Georgia, UNITED STATES
| | - M Bell
- Division of High-Consequence Pathogens and Pathology; Bacterial Special Pathogens Branch, Centers for Disease Control and Prevention, Atlanta, Georgia, UNITED STATES
| | - A Kelly
- Division of High-Consequence Pathogens and Pathology; Bacterial Special Pathogens Branch, Centers for Disease Control and Prevention, Atlanta, Georgia, UNITED STATES
| | - B Humrighouse
- Division of High-Consequence Pathogens and Pathology; Bacterial Special Pathogens Branch, Centers for Disease Control and Prevention, Atlanta, Georgia, UNITED STATES
| | - J McQuiston
- Division of High-Consequence Pathogens and Pathology; Bacterial Special Pathogens Branch, Centers for Disease Control and Prevention, Atlanta, Georgia, UNITED STATES
| |
Collapse
|
10
|
Langton A, Chien A, Kang S, Rhodes L, O’Connor C, Bell M, Griffiths C, Watson R. 148 Fibrillin-rich microfibrils: Key components of dermal-epidermal junction architecture? J Invest Dermatol 2021. [DOI: 10.1016/j.jid.2021.08.151] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
|
11
|
Heinrich L, Haufe E, Abraham S, Heratizadeh A, Harder I, Kleinheinz A, Wollenberg A, Weisshaar E, Wiemers F, Ertner K, Schäkel K, Augustin M, Wildberger J, von Kiedrowski R, Zink A, Pawlak M, Worm M, Sticherling M, Effendy I, Hilgers M, Quist S, Asmussen A, Handrick C, Bell M, Staubauch-Renz P, Schwarz B, Hong-Weldemann SH, Homey B, Werfel T, Weidinger S, Schmitt J. Einschätzung der Erkrankungsschwere der Neurodermitis durch Ärzte und Patienten in Abhängigkeit vom Geschlecht: Ergebnisse aus dem Deutschen Neurodermitisregister TREATgermany+. Das Gesundheitswesen 2021. [DOI: 10.1055/s-0041-1732223] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
Affiliation(s)
- L Heinrich
- Zentrum für Evidenzbasierte Gesundheitsversorgung, Universitätsklinikum und Medizinische Fakultät Carl Gustav Carus, TU Dresden
| | - E Haufe
- Zentrum für Evidenzbasierte Gesundheitsversorgung, Universitätsklinikum und Medizinische Fakultät Carl Gustav Carus, TU Dresden
| | - S Abraham
- Universitäts AllergieCentrum Dresden, Klinik für Dermatologie, Universitätsklinikum Carl Gustav Carus
| | - A Heratizadeh
- Klinik für Dermatologie, Allergologie und Venerologie, Medizinische Hochschule Hannover
| | - I Harder
- Zentrum für Entzündliche Hauterkrankungen, Klinik für Dermatologie und Allergologie, Universitäts-klinikum Schleswig-Holstein, Campus Kiel
| | | | - A Wollenberg
- Klinik und Poliklinik für Dermatologie und Allergologie, LMU München
| | - E Weisshaar
- Berufsdermatologie, Klinik für Dermatologie, Universität Heidelberg
| | - F Wiemers
- Praxis Dr. Ulrike Wiemers/Dr. Franca Wiemers
| | | | - K Schäkel
- Klinik für Dermatologie, Universität Heidelberg
| | - M Augustin
- Institut für Versorgungsforschung in der Dermatologie und bei Pflegeberufen (IVDP), Universitätsklinikum Hamburg-Eppendorf
| | | | | | - A Zink
- Klinik für Dermatologie und Allergologie, TU München & Zentrum für Umweltmedizin GmbH
| | - M Pawlak
- Praxis Dr. Anika Hünermund, Mario Pawlak
| | - M Worm
- Klinik für Dermatologie, Venerologie und Allergologie, Charité Berlin
| | - M Sticherling
- Klinik für Dermatologie, Universität Erlangen-Nürnberg
| | - I Effendy
- Klinik für Dermatologie, Klinikum Rosenhöhe
| | - M Hilgers
- Universitätsklinikum Aachen, Uniklinik RWTH Aachen
| | | | - A Asmussen
- Praxis Dr. Andrea Asmussen, Dermatologie an der Lesum
| | | | - M Bell
- Praxis Dr. Magnus Bell, Thomas Kaiser
| | - P Staubauch-Renz
- Klinik für Dermatologie und Allergologie, Universitätsklinikum Mainz
| | | | | | - B Homey
- Klinik für Dermatologie, Universität Düsseldorf
| | - T Werfel
- Klinik für Dermatologie, Allergologie und Venerologie, Medizinische Hochschule Hannover
| | - S Weidinger
- Zentrum für Entzündliche Hauterkrankungen, Klinik für Dermatologie und Allergologie, Universitätsklinikum Schleswig-Holstein, Campus Kiel
| | - J Schmitt
- Zentrum für Evidenzbasierte Gesundheitsversorgung, Universitätsklinikum und Medizinische Fakultät Carl Gustav Carus, TU Dresden
| | | |
Collapse
|
12
|
Helmert C, Haufe E, Abraham S, Heratizadeh A, Harder I, Kleinheinz A, Wollenberg A, Wiemers F, Weisshaar E, Augustin M, von Kiedrowski R, Wildberg J, Pawlak M, Hilgers M, Worm M, Schäkel K, Sticherling M, Effendy I, Staubach-Renz P, Handrick C, Bell M, Asmussen A, Schwarz B, Werfel T, Weidinger S, Schmitt J. Fatigue und Neurodermitis: Ergebnisse aus dem deutschen Neurodermitisregister TREATgermany. Das Gesundheitswesen 2021. [DOI: 10.1055/s-0041-1732225] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
Affiliation(s)
- C Helmert
- Zentrum für evidenzbasierte Gesundheitsversorgung, Medizinische Fakultät Carl Gustav Carus, TU Dresden
| | - E Haufe
- Zentrum für evidenzbasierte Gesundheitsversorgung, Medizinische Fakultät Carl Gustav Carus, TU Dresden
| | - S Abraham
- UniversitätsAllergieZentrum, Klinik für Dermatologie, Universitätsklinikum Carl Gustav Carus
| | - A Heratizadeh
- Klinik für Dermatologie, Allergologie und Venerologie, Medizinische Hochschule Hannover
| | - I Harder
- Zentrum für entzündliche Hauterkrankungen an der Klinik für Dermatologie und Allergologie, Universitätsklinikum Schleswig-Holstein, Campus Kiel
| | | | - A Wollenberg
- Klinik und Poliklinik für Dermatologie und Allergologie, Ludwig-Maximilians-Universität München
| | | | - E Weisshaar
- Berufsdermatologie, Universitätsklinikum Heidelberg
| | - M Augustin
- Institut für Versorgugnsforschung in der Dermatologie und Pflegeberufe, Universitätsklinikum Hamburg-Eppendorf
| | - R von Kiedrowski
- CMSS - Company for Medical Study and Service Selters, Dermatologische Spezialpraxis
| | | | | | - M Hilgers
- Klinik für Dermatologie und Allergologie, Universitätsklinikum Aachen
| | - M Worm
- Klinik für Dermatologie, Venerologie und Allergologie, Charité Universitätsmedizin Berlin
| | | | | | - I Effendy
- Hautklinik, Klinikum Bielefeld Rosenhöhe
| | - P Staubach-Renz
- Universitätshautklinik und poliklinik, Universitätsmedizin Mainz
| | - C Handrick
- Praxis, für Haut- und Geschlechtskrankheiten
| | | | | | - B Schwarz
- Praxis, Dermatologie und Allergologie
| | - T Werfel
- Klinik für Dermatologie, Allergologie und Venerologie, Medizinische Hochschule Hannover
| | - S Weidinger
- Zentrum für entzündliche Hauterkrankungen an der Klinik für Dermatologie und Allergologie, Universitätsklinikum Schleswig-Holstein, Campus Kiel
| | - J Schmitt
- Zentrum für evidenzbasierte Gesundheitsversorgung, Medizinische Fakultät Carl Gustav Carus, TU Dresden
| |
Collapse
|
13
|
O’Mahony M, Sladen C, Crone M, Banner E, Newton V, Allen A, Bell M, Marlow I, Acevedo S, Jiang L. A validated photonumeric scale for infraorbital dark circles and its application in evaluating the efficacy of a cosmetic treatment product in a split-face randomized clinical trial. Int J Cosmet Sci 2021; 43:48-56. [PMID: 33038017 PMCID: PMC7898348 DOI: 10.1111/ics.12668] [Citation(s) in RCA: 6] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/28/2020] [Accepted: 10/05/2020] [Indexed: 11/30/2022]
Abstract
OBJECTIVE As a result of their complex aetiology and periodicity, dark circles are difficult to characterize and measure, with current assessment techniques relying on specialist equipment, image analysis or proprietary grading scales. There is therefore a need to develop and validate a photonumeric scale for assessing infraorbital dark circles, which can provide an objective and consumer relevant tool for evaluating this condition and the efficacy of treatment products and procedures. METHODS A panel of expert clinical evaluators reviewed approximately three thousand facial photographs collected over a 5-year period and selected images representing a dynamic range of dark circles. A 10-point photonumeric scale was created, with corresponding descriptors and images for each grade of the scale. To rigorously validate the scale, linearity, sensitivity and precision were assessed by colorimetry and in-clinic evaluation. Reproducibility was assessed photographically with both experienced and inexperienced clinical evaluators, whereas intragrader repeatability was assessed live in-clinic. The scale was then employed in a split-face randomized clinical trial on 58 subjects to evaluate the efficacy of a cosmetic treatment product over 8 weeks. RESULTS Colour analysis of the images showed the scale was linear, with statistically significant correlations observed when colour data (CIElab; Individual Typology Angle) were plotted against the corresponding grades (r > 0.9, P < 0.001). Colour difference (Delta E) was calculated between the infraorbital zone and the surrounding skin, and when data were plotted against the grades, a statistically significant correlation was observed (r = 0.99, P < 0.01). The magnitude of the Delta E suggested that changes in grade are visibly perceptible to the human eye, and therefore, the scale is sensitive and clinically relevant. Intergrader reproducibility showed strong correlation (0.96) and >90% agreement between experienced evaluators, whereas intragrader repeatability assessment showed >90% perfect agreement between grades. Use of this scale in a clinical trial demonstrated the efficacy of a cosmetic product, with a mean statistically significant (P < 0.001) decrease in grade of 0.74 compared to baseline, and 0.59 versus the untreated control, after 8 weeks of treatment. CONCLUSION Our photonumeric scale for infraorbital dark circles is sensitive and robust and provides an objective and easy-to-use tool to evaluate dark circles and their treatment.
Collapse
Affiliation(s)
- M.M. O’Mahony
- Walgreens Boots AllianceThane RoadNottinghamNG90 1BSUK
| | - C. Sladen
- Walgreens Boots AllianceThane RoadNottinghamNG90 1BSUK
| | - M. Crone
- Walgreens Boots AllianceThane RoadNottinghamNG90 1BSUK
| | - E. Banner
- Walgreens Boots AllianceThane RoadNottinghamNG90 1BSUK
| | - V.L. Newton
- Walgreens Boots AllianceThane RoadNottinghamNG90 1BSUK
| | - A. Allen
- Walgreens Boots AllianceThane RoadNottinghamNG90 1BSUK
| | - M. Bell
- Walgreens Boots AllianceThane RoadNottinghamNG90 1BSUK
| | - I. Marlow
- Walgreens Boots AllianceThane RoadNottinghamNG90 1BSUK
| | - S.F. Acevedo
- SGS Stephens1801 N. Glenville DriveRichardsonTX75081USA
| | - L.I. Jiang
- SGS Stephens1801 N. Glenville DriveRichardsonTX75081USA
| |
Collapse
|
14
|
O'Neill SM, Clyne B, Bell M, Casey A, Leen B, Smith SM, Ryan M, O'Neill M. Why do healthcare professionals fail to escalate as per the early warning system (EWS) protocol? A qualitative evidence synthesis of the barriers and facilitators of escalation. BMC Emerg Med 2021; 21:15. [PMID: 33509099 PMCID: PMC7842002 DOI: 10.1186/s12873-021-00403-9] [Citation(s) in RCA: 21] [Impact Index Per Article: 7.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/02/2020] [Accepted: 01/08/2021] [Indexed: 12/23/2022] Open
Abstract
Background Early warning systems (EWSs) are used to assist clinical judgment in the detection of acute deterioration to avoid or reduce adverse events including unanticipated cardiopulmonary arrest, admission to the intensive care unit and death. Sometimes healthcare professionals (HCPs) do not trigger the alarm and escalate for help according to the EWS protocol and it is unclear why this is the case. The aim of this qualitative evidence synthesis was to answer the question ‘why do HCPs fail to escalate care according to EWS protocols?’ The findings will inform the update of the National Clinical Effectiveness Committee (NCEC) National Clinical Guideline No. 1 Irish National Early Warning System (INEWS). Methods A systematic search of the published and grey literature was conducted (until February 2018). Data extraction and quality appraisal were conducted by two reviewers independently using standardised data extraction forms and quality appraisal tools. A thematic synthesis was conducted by two reviewers of the qualitative studies included and categorised into the barriers and facilitators of escalation. GRADE CERQual was used to assess the certainty of the evidence. Results Eighteen studies incorporating a variety of HCPs across seven countries were included. The barriers and facilitators to the escalation of care according to EWS protocols were developed into five overarching themes: Governance, Rapid Response Team (RRT) Response, Professional Boundaries, Clinical Experience, and EWS parameters. Barriers to escalation included: Lack of Standardisation, Resources, Lack of accountability, RRT behaviours, Fear, Hierarchy, Increased Conflict, Over confidence, Lack of confidence, and Patient variability. Facilitators included: Accountability, Standardisation, Resources, RRT behaviours, Expertise, Additional support, License to escalate, Bridge across boundaries, Clinical confidence, empowerment, Clinical judgment, and a tool for detecting deterioration. These are all individual yet inter-related barriers and facilitators to escalation. Conclusions The findings of this qualitative evidence synthesis provide insight into the real world experience of HCPs when using EWSs. This in turn has the potential to inform policy-makers and HCPs as well as hospital management about emergency response system-related issues in practice and the changes needed to address barriers and facilitators and improve patient safety and quality of care. Supplementary Information The online version contains supplementary material available at 10.1186/s12873-021-00403-9.
Collapse
Affiliation(s)
- S M O'Neill
- The Health Information and Quality Authority (HIQA), City Gate, Mahon, Cork, T12 Y2XT, Ireland.
| | - B Clyne
- The Health Information and Quality Authority (HIQA), City Gate, Mahon, Cork, T12 Y2XT, Ireland.,HRB Centre for Primary Care Research and Department of General Practice, Royal College of Surgeons in Ireland, Dublin, Ireland
| | - M Bell
- The Deteriorating Patient Recognition and Response Improvement Programme (DPIP), Clinical Design and Innovation, Health Service Executive, Dr. Steeven's Hospital, Steevens' Lane, D08W2A8, Dublin, Ireland
| | - A Casey
- The Deteriorating Patient Recognition and Response Improvement Programme (DPIP), Clinical Design and Innovation, Health Service Executive, Dr. Steeven's Hospital, Steevens' Lane, D08W2A8, Dublin, Ireland
| | - B Leen
- Regional Librarian, Health Service Executive South, Kilkenny, Ireland
| | - S M Smith
- HRB Centre for Primary Care Research and Department of General Practice, Royal College of Surgeons in Ireland, Dublin, Ireland
| | - M Ryan
- The Health Information and Quality Authority (HIQA), City Gate, Mahon, Cork, T12 Y2XT, Ireland
| | - M O'Neill
- The Health Information and Quality Authority (HIQA), City Gate, Mahon, Cork, T12 Y2XT, Ireland
| |
Collapse
|
15
|
Kelada O, Gutsche N, Bell M, Berman R, Baidoo K, Warner B, Szajek L, Hong J, Ho M, Choyke P, Escorcia F. ImmunoPET as Stoichiometric Sensor for Glypican-3 in Models of Hepatocellular Carcinoma. Int J Radiat Oncol Biol Phys 2020. [DOI: 10.1016/j.ijrobp.2020.07.966] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
|
16
|
Buckingham J, Capper A, Bell M. The missing sink - quantification, categorisation and sourcing of beached macro-debris in the Scottish Orkney Islands. Mar Pollut Bull 2020; 157:111364. [PMID: 32658709 DOI: 10.1016/j.marpolbul.2020.111364] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 11/11/2019] [Revised: 06/06/2020] [Accepted: 06/06/2020] [Indexed: 06/11/2023]
Abstract
Around the coastline of the UK, macro-debris has been observed in average densities of over 700 items per metre. Systematic beach-cleans were conducted at 35 sites around the Scottish Orkney Islands, in order to quantify and categorise the level of marine debris found there. Litter was collected from 100 m transects and categorised by its material, broad source (terrestrial or marine) and potential sector source. Variation between sites, and the relative contribution of pre-determined environmental variables in influencing said variation, were analysed using the "capscale" function for a canonical analysis of principle coordinates (CAP). 513 items/m were observed, (77% plastic), with "String/cord (<1cm diameter)" being the most abundant and widely distributed litter type. 47% of macro-debris was attributed to the fishing sector and < 10% to leisure, living and tourism-associated activities. Conversely, the unique regional hydrodynamics must be examined further, before the source of any given item can be categorically assigned.
Collapse
Affiliation(s)
- J Buckingham
- Heriot- Watt University, International Centre for Island Technology, Stromness, Orkney KW16 3AW, Scotland, United Kingdom of Great Britain and Northern Ireland.
| | - A Capper
- Heriot- Watt University, International Centre for Island Technology, Stromness, Orkney KW16 3AW, Scotland, United Kingdom of Great Britain and Northern Ireland; Central Queensland University, Coastal Marine Ecosystems Research Centre, Gladstone, QLD 4680, Australia
| | - M Bell
- Heriot- Watt University, International Centre for Island Technology, Stromness, Orkney KW16 3AW, Scotland, United Kingdom of Great Britain and Northern Ireland
| |
Collapse
|
17
|
Mellody K, Bradley E, Bell M, Halai P, Cotterell L, Griffiths C, Watson R. 238 Retinol at a concentration of 0.3% restores fibrillin-rich microfibrils and modifies the epidermis in photoaged human skin in vivo in a manner similar to 1% retinol. J Invest Dermatol 2020. [DOI: 10.1016/j.jid.2020.03.243] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/24/2022]
|
18
|
Heratizadeh A, Haufe E, Stölzl D, Abraham S, Heinrich L, Kleinheinz A, Wollenberg A, Weisshaar E, Augustin M, Wiemers F, Zink A, von Kiedrowski R, Hilgers M, Worm M, Pawlak M, Sticherling M, Fell I, Handrick C, Schäkel K, Staubach-Renz P, Asmussen A, Schwarz B, Bell M, Effendy I, Bieber T, Homey B, Gerlach B, Tchitcherina E, Stahl M, Schwichtenberg U, Rossbacher J, Buck P, Mempel M, Beissert S, Biedermann T, Weidinger S, Schmitt J, Werfel T. Baseline characteristics, disease severity and treatment history of patients with atopic dermatitis included in the German AD Registry TREATgermany. J Eur Acad Dermatol Venereol 2020; 34:1263-1272. [PMID: 31721316 DOI: 10.1111/jdv.16078] [Citation(s) in RCA: 38] [Impact Index Per Article: 9.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/10/2019] [Accepted: 10/17/2019] [Indexed: 01/26/2023]
Abstract
BACKGROUND The Atopic Dermatitis (AD) TREATgermany registry was initiated by the German Society for Dermatology (DDG) in 2011 to evaluate the 'real-life' situation of health care for patients with AD. OBJECTIVES Interim data analysis on baseline characteristics as well as current and prescribed systemic treatments of the TREATgermany registry patients. METHODS Patients (≥18 years) with moderate-to-severe AD [objective (o)SCORAD > 20], or with current or previous anti-inflammatory systemic treatment for AD within 24 months, were included and are followed up over at least 24 months. To assess clinical signs, the eczema area severity index (EASI, 0-72), the oSCORAD (0-83) and the Investigator Global Assessment (IGA; 6-point scale) were used. The disease severity was globally scored by the patients [Patient Global Assessment (PGA); six-step Likert scale]. Disease symptoms were assessed by the patient-oriented eczema measure (POEM, 0-28) and numeric rating scales (NRS, 0-10). Health-related quality of life was measured using the dermatological life quality index (DLQI, 0-30). RESULTS A total of 612 patients were recruited across 32 sites between 06/2016 and 01/2019 (mean age: 42.6 ± 14.2 years; mean oSCORAD: 40.8 ± 16.3). The mean POEM score was 16.3 ± 7.5. Pruritus was rated highest among subjective symptoms (NRS: 5.4 ± 2.7). The mean DLQI value was 11.3 ± 7.5. The frequency of arterial hypertension was lower (20.8%) compared with the general population, whilst this was higher for depression (10%). More than 60% of the patients had received systemic glucocorticosteroids, and 36.8% had received cyclosporine A prior to inclusion. Dupilumab was the leading substance documented as either 'current' (12.1%) or 'prescribed' (31.4%) at baseline. CONCLUSIONS These 'real-life' data clearly demonstrate the substantial disease burden. Most of TREATgermany patients were already treated with or prescribed dupilumab at baseline. Moreover, current findings indicate the urgent need for further alternative agents in order to achieve a perceptible improvement of quality of life of patients with moderate-to-severe AD.
Collapse
Affiliation(s)
- A Heratizadeh
- Division of Immunodermatology and Allergy Research, Department of Dermatology and Allergy, Hannover Medical School, Hannover, Germany
| | - E Haufe
- Center of Evidence-based Healthcare, University Hospital and Medical Faculty Carl Gustav Carus, TU Dresden, Dresden, Germany
| | - D Stölzl
- Department of Dermatology and Allergy, Center for Inflammatory Skin Diseases, University Hospital Schleswig-Holstein, Campus Kiel, Kiel, Germany
| | - S Abraham
- Department of Dermatology, University Allergy Center, Medical Faculty Carl Gustav Carus, TU Dresden, Dresden, Germany
| | - L Heinrich
- Center of Evidence-based Healthcare, University Hospital and Medical Faculty Carl Gustav Carus, TU Dresden, Dresden, Germany
| | - A Kleinheinz
- Clinics for Dermatology, Elbe Klinikum Buxtehude, Buxtehude, Germany
| | - A Wollenberg
- Clinics and Outpatient Clinics for Dermatology and Allergy, LMU Munich, Munich, Germany
| | - E Weisshaar
- Occupational Dermatology, Department of Dermatology, University Hospital Heidelberg, Heidelberg, Germany
| | - M Augustin
- Insitute for Health Services Research in Dermatology Hamburg, University Medical Center Hamburg Eppendorf, Hamburg, Germany
| | - F Wiemers
- Practice Dr. med. Franca Wiemers, Leipzig, Germany
| | - A Zink
- Department of Dermatology and Allergy, School of Medicine, Technical University of Munich, Munich, Germany.,Clinical Unit Allergology, Helmholtz Zentrum München, German Research Center for Environmental Health GmbH, Munich, Germany
| | - R von Kiedrowski
- CMSS - Company for Medical Study and Service, Selters/Westerwald, Germany
| | - M Hilgers
- Clinics for Dermatology and Allergy, University Hospital Aachen, Aachen, Germany
| | - M Worm
- Division of Allergy and Immunology, Department of Dermatology, Venerology and Allergy, Charité Universitätsmedizin Berlin, Berlin, Germany
| | - M Pawlak
- Practice Dr. med. Anika Hünermund and Mario Pawlak, Heilbad Heiligenstadt, Germany
| | - M Sticherling
- Department of Dermatology, University Hospital, Friedrich Alexander University Erlangen-Nurnberg, Erlangen, Germany
| | - I Fell
- Hautmedizin Bad Soden, Bad Soden, Germany
| | - C Handrick
- Practice Dr. med. Christiane Handrick, Berlin, Germany
| | - K Schäkel
- Department of Dermatology, Ruprecht-Karls University Heidelberg, Heidelberg, Germany
| | - P Staubach-Renz
- Department of Dermatology and Allergy, University Medical Center Mainz, Mainz, Germany
| | - A Asmussen
- Practice Dermatologie an der Lesum, Bremen, Germany
| | - B Schwarz
- Practice Dr. med. Beate Schwarz, Langenau, Germany
| | - M Bell
- Practice Dr. Magnus Bell, Thomas Kaiser, Andernach, Germany
| | - I Effendy
- Department of Dermatology, Hospital Rosenhoehe, Bielefeld, Germany
| | - T Bieber
- Department of Dermatology and Allergy, Rheinische Friedrich-Wilhelms-University Bonn, Bonn, Germany
| | - B Homey
- Department of Dermatology, Heinrich-Heine-University Duesseldorf, Düsseldorf, Germany
| | - B Gerlach
- Practice Dr. med. Beatrice Gerlach, Dresden, Germany
| | - E Tchitcherina
- Practice Dr. med. Ekaterina Tchitcherina, Friedberg/Hessen, Germany
| | - M Stahl
- Practice Dr. med. Maren Stahl, Osterode, Germany
| | | | | | - P Buck
- Goldbek Medical, Hamburg, Germany
| | - M Mempel
- Practice Prof. Dr. med. Martin Mempel, Elmshorn, Germany
| | - S Beissert
- Department of Dermatology, University Allergy Center, Medical Faculty Carl Gustav Carus, TU Dresden, Dresden, Germany
| | - T Biedermann
- Department of Dermatology and Allergy, School of Medicine, Technical University of Munich, Munich, Germany.,Clinical Unit Allergology, Helmholtz Zentrum München, German Research Center for Environmental Health GmbH, Munich, Germany
| | - S Weidinger
- Department of Dermatology and Allergy, Center for Inflammatory Skin Diseases, University Hospital Schleswig-Holstein, Campus Kiel, Kiel, Germany
| | - J Schmitt
- Center of Evidence-based Healthcare, University Hospital and Medical Faculty Carl Gustav Carus, TU Dresden, Dresden, Germany
| | - T Werfel
- Division of Immunodermatology and Allergy Research, Department of Dermatology and Allergy, Hannover Medical School, Hannover, Germany
| | | |
Collapse
|
19
|
Abraham S, Haufe E, Harder I, Heratizadeh A, Kleinheinz A, Wollenberg A, Weisshaar E, Augustin M, Wiemers F, Zink A, Biedermann T, von Kiedrowski R, Hilgers M, Worm M, Pawlak M, Sticherling M, Fell I, Handrick C, Schäkel K, Staubach P, Asmussen A, Schwarz B, Bell M, Neubert K, Effendy I, Bieber T, Homey B, Gerlach B, Tchitcherina E, Stahl M, Schwichtenberg U, Rossbacher J, Buck P, Mempel M, Beissert S, Werfel T, Weidinger S, Schmitt J. Implementation of dupilumab in routine care of atopic eczema: results from the German national registry TREATgermany. Br J Dermatol 2020; 183:382-384. [PMID: 32068242 DOI: 10.1111/bjd.18958] [Citation(s) in RCA: 28] [Impact Index Per Article: 7.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/25/2022]
Affiliation(s)
- S Abraham
- Department of Dermatology, University Allergy Center, Medical Faculty Carl Gustav Carus, TU Dresden, Dresden, Germany
| | - E Haufe
- Center of Evidence-Based Healthcare, University Hospital and Medical Faculty Carl Gustav Carus, TU Dresden, Dresden, Germany
| | - I Harder
- Center for Inflammatory Skin Diseases, Department of Dermatology and Allergy, University Hospital Schleswig-Holstein, Campus Kiel, Kiel, Germany
| | - A Heratizadeh
- Division of Immunodermatology and Allergy Research, Department of Dermatology and Allergy, Hannover Medical School, Hannover, Germany
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | - S Beissert
- Department of Dermatology, University Allergy Center, Medical Faculty Carl Gustav Carus, TU Dresden, Dresden, Germany
| | - T Werfel
- Division of Immunodermatology and Allergy Research, Department of Dermatology and Allergy, Hannover Medical School, Hannover, Germany
| | - S Weidinger
- Center for Inflammatory Skin Diseases, Department of Dermatology and Allergy, University Hospital Schleswig-Holstein, Campus Kiel, Kiel, Germany
| | - J Schmitt
- Center of Evidence-Based Healthcare, University Hospital and Medical Faculty Carl Gustav Carus, TU Dresden, Dresden, Germany
| | | |
Collapse
|
20
|
Bogdanet D, Griffin TP, Bell M. A Rare Case of Infertility: SRY Positive 46, XX Testicular Disorder of Sexual Differentiation. Ir Med J 2020:60. [PMID: 32268053] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/11/2023]
Abstract
Aim To highlight the complexity of infertility causes by describing the rare case of a man with a testicular disorder of sexual differentiation. Diagnosis A 33 years old Caucasian male presented with a 3-year-old history of primary infertility. His investigations revealed a low testosterone and a raised LH and FSH levels. A sample sent for sperm analysis revealed azoospermia. Chromosomal analysis and karyotyping revealed a 46 XX SRY positive karyotype. Treatment The patient was initiated on testosterone replacement and on calcium/vitamin D supplements. Conclusion Fertility evaluation requires complex assessments and a broad knowledge of possible causes.
Collapse
Affiliation(s)
- D Bogdanet
- Galway University Hospital, Galway, Ireland
- National University of Ireland Galway, Galway, Ireland
| | - T P Griffin
- Galway University Hospital, Galway, Ireland
- National University of Ireland Galway, Galway, Ireland
| | - M Bell
- Galway University Hospital, Galway, Ireland
| |
Collapse
|
21
|
Sheridan A, Kemple M, Hyde A, Fox P, Furlong E, Coughlan B, Bell M, Naughton C, Carberry S, Drennan J. Non-use of cancer information services among people experiencing cancer in Ireland. Eur J Oncol Nurs 2020; 44:101700. [PMID: 32007695 DOI: 10.1016/j.ejon.2019.101700] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/13/2019] [Revised: 11/20/2019] [Accepted: 11/24/2019] [Indexed: 12/22/2022]
Abstract
PURPOSE The purpose of this study was to explore the reasons for non-use of a national cancer society's cancer information services among people experiencing cancer. METHOD This study used a qualitative design. Semi-structured interviews were conducted with a total of 17 participants who had not previously utilised the Cancer Society's information services. Data were analysed using Thematic Analysis. RESULTS The key themes to emerge from the date were 'living in the here and now' and 'awareness of the Cancer Society'. For most participants, not utilising cancer information services was a means of coping with the initial diagnosis and the impact of treatment. Those who progressed to being ready to seek information identified the multi-disciplinary team as the primary source of trusted information, with particular mention of cancer nurse specialists. For participants with children, their role as a parent was central in how they managed their diagnosis. The majority of participants lacked awareness of the range of services provided by the Cancer Society. CONCLUSIONS Reasons for non-use of cancer information services were identified as: readiness to seek information and a lack of knowledge of the Cancer Societies' services. Cancer information services need to continue make a concerted effort to enhance visibility and awareness of its services to optimise patient engagement.
Collapse
Affiliation(s)
- A Sheridan
- School of Nursing, Midwifery and Health Systems, University College Dublin, Dublin 4, Ireland.
| | - M Kemple
- School of Nursing, Midwifery and Health Systems, University College Dublin, Dublin 4, Ireland
| | - A Hyde
- School of Nursing, Midwifery and Health Systems, University College Dublin, Dublin 4, Ireland
| | - P Fox
- School of Nursing, Midwifery and Health Systems, University College Dublin, Dublin 4, Ireland
| | - E Furlong
- School of Nursing, Midwifery and Health Systems, University College Dublin, Dublin 4, Ireland
| | - B Coughlan
- School of Nursing, Midwifery and Health Systems, University College Dublin, Dublin 4, Ireland
| | - M Bell
- Our Lady's Hospice and Care Services, Harold's Cross, Dublin, Ireland
| | - C Naughton
- School of Nursing and Midwifery, University College Cork, Cork, Ireland
| | - S Carberry
- School of Nursing, Midwifery and Health Systems, University College Dublin, Dublin 4, Ireland
| | - J Drennan
- School of Nursing and Midwifery, University College Cork, Cork, Ireland
| |
Collapse
|
22
|
Young A, Narbutt J, Harrison G, Lawrence K, Bell M, O'Connor C, Olson P, Grys K, Baczynska K, Rogowski‐Tylman M, Wulf H, Lesiak A, Philipsen P. 使用最佳防晒霜可促进维生素 D 合成. Br J Dermatol 2019. [DOI: 10.1111/bjd.18504] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
|
23
|
Young A, Narbutt J, Harrison G, Lawrence K, Bell M, O'Connor C, Olson P, Grys K, Baczynska K, Rogowski‐Tylman M, Wulf H, Lesiak A, Philipsen P. Optimal sunscreen use allows vitamin D synthesis. Br J Dermatol 2019. [DOI: 10.1111/bjd.18492] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
24
|
Castellano Pellicena I, O’Connor C, Bell M, Tobin D. 524 Melanin localisation and transport in the human epidermis. J Invest Dermatol 2019. [DOI: 10.1016/j.jid.2019.07.439] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|
25
|
Mellody K, Bradley E, Halai P, Cotterell L, Horn J, Griffiths C, Bell M, Watson R. 610 Hibiscus abelmoschus seed extract induces remodelling of the papillary dermal fibrillin-rich microfibrils. J Invest Dermatol 2019. [DOI: 10.1016/j.jid.2019.07.614] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
|
26
|
Affiliation(s)
- M Costello
- From the Department of Diabetes, Endocrinology and Metabolism University College Hospital Galway, Galway, Ireland
| | - M Brennan
- Department of Geriatric Medicine University College Hospital Galway, Galway, Ireland
| | - C Newman
- From the Department of Diabetes, Endocrinology and Metabolism University College Hospital Galway, Galway, Ireland
| | - P O'Shea
- Department of Clinical Biochemistry, University College Hospital Galway, Galway, Ireland
| | - M Bell
- From the Department of Diabetes, Endocrinology and Metabolism University College Hospital Galway, Galway, Ireland
| |
Collapse
|
27
|
Ramalingam G, Choi S, Agarwal S, Kunst G, Gill R, Fletcher SN, Klein AA, Shashidaran P, Waghmare K, Kadayam R, Flynn F, Gavin N, Mairead‐Machugh U, Bell M, Hawthorn A, Sajgalik P, Burri N, Meraglia A. Complications related to peri‐operative transoesophageal echocardiography – a one‐year prospective national audit by the Association of Cardiothoracic Anaesthesia and Critical Care. Anaesthesia 2019; 75:21-26. [DOI: 10.1111/anae.14734] [Citation(s) in RCA: 37] [Impact Index Per Article: 7.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 05/16/2019] [Indexed: 12/26/2022]
Affiliation(s)
- G. Ramalingam
- Department of Anaesthesia and Intensive Care Royal Papworth Hospital CambridgeUK
| | - S.‐W. Choi
- Department of Anaesthesiology Faculty of Medicine The University of Hong Kong HongKongHKSAR
| | - S. Agarwal
- Department of Cardiothoracic Anaesthesia Manchester Royal Infirmary ManchesterUK
| | - G. Kunst
- Department of Cardiothoracic Anaesthesia Kings College Hospital LondonUK
| | - R. Gill
- Department of Cardiothoracic Anaesthesia University Hospital Southampton UK
| | - S. N. Fletcher
- Department of Cardiothoracic Anaesthesia St Georges University Hospitals London UK
| | - A. A. Klein
- Department of Anaesthesia and Intensive Care Royal Papworth Hospital CambridgeUK
| | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
28
|
Young AR, Narbutt J, Harrison GI, Lawrence KP, Bell M, O'Connor C, Olsen P, Grys K, Baczynska KA, Rogowski-Tylman M, Wulf HC, Lesiak A, Philipsen PA. Optimal sunscreen use, during a sun holiday with a very high ultraviolet index, allows vitamin D synthesis without sunburn. Br J Dermatol 2019; 181:1052-1062. [PMID: 31069787 PMCID: PMC6899952 DOI: 10.1111/bjd.17888] [Citation(s) in RCA: 39] [Impact Index Per Article: 7.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 03/14/2019] [Indexed: 12/17/2022]
Abstract
Background Sunlight contains ultraviolet (UV)A and UVB radiation. UVB is essential for vitamin D synthesis but is the main cause of sunburn and skin cancer. Sunscreen use is advocated to reduce the sun's adverse effects but may compromise vitamin D status. Objectives To assess the ability of two intervention sunscreens to inhibit vitamin D synthesis during a week‐long sun holiday. Methods The impact of sunscreens on vitamin D status was studied during a 1‐week sun holiday in Tenerife (28° N). Comparisons were made between two formulations, each with a sun protection factor (SPF) of 15. The UVA‐protection factor (PF) was low in one case and high in the other. Healthy Polish volunteers (n = 20 per group) were given the sunscreens and advised on the correct application. Comparisons were also made with discretionary sunscreen use (n = 22) and nonholiday groups (51·8° N, n = 17). Sunscreen use in the intervention groups was measured. Behaviour, UV radiation exposure, clothing cover and sunburn were monitored. Serum 25‐hydroxyvitamin D3 [25(OH)D3] was assessed by high‐performance liquid chromatography–tandem mass spectrometry. Results Use of intervention sunscreens was the same (P = 0·60), and both equally inhibited sunburn, which was present in the discretionary use group. There was an increase (P < 0·001) in mean ± SD 25(OH)D3 (28·0 ± 16·5 nmol L−1) in the discretionary use group. The high and low UVA‐PF sunscreen groups showed statistically significant increases (P < 0·001) of 19·0 ± 14·2 and 13·0 ± 11·4 nmol L−1 25(OH)D3, respectively with P = 0·022 for difference between the intervention sunscreens. The nonholiday group showed a fall (P = 0·08) of 2·5 ± 5·6 nmol L−1 25(OH)D3. Conclusions Sunscreens may be used to prevent sunburn yet allow vitamin D synthesis. A high UVA‐PF sunscreen enables significantly higher vitamin D synthesis than a low UVA‐PF sunscreen because the former, by default, transmits more UVB than the latter. What's already known about this topic? Action spectra (wavelength dependence) for erythema and the cutaneous formation of vitamin D overlap considerably in the ultraviolet (UV)B region. Theoretically, sunscreens that inhibit erythema should also inhibit vitamin D synthesis. To date, studies on the inhibitory effects of sunscreens on vitamin D synthesis have given conflicting results, possibly, in part, because people typically apply sunscreen suboptimally. Many studies have design flaws.
What does this study add? Sunscreens (sun protection factor, SPF 15) applied at sufficient thickness to inhibit sunburn during a week‐long holiday with a very high UV index still allow a highly significant improvement of serum 25‐hydroxyvitamin D3 concentration. An SPF 15 formulation with high UVA protection enables better vitamin D synthesis than a low UVA protection product. The former allows more UVB transmission.
Linked Editorial: https://doi.org/10.1111/bjd.18273. https://doi.org/10.1111/bjd.18492 available online https://www.bjdonline.com/article/optimal-sunscreen-use-during-a-sun-holiday-with-a-very-high-ultraviolet-index-allows-vitamin-d-synthesis-without-sunburn/
Collapse
Affiliation(s)
- A R Young
- King's College London, St John's Institute of Dermatology, London, SE1 9RT, U.K
| | - J Narbutt
- Medical University of Łódź, Department of Dermatology, Pediatric Dermatology and Dermatological Oncology, Łódź, 90-647, Poland
| | - G I Harrison
- King's College London, St John's Institute of Dermatology, London, SE1 9RT, U.K
| | - K P Lawrence
- King's College London, St John's Institute of Dermatology, London, SE1 9RT, U.K
| | - M Bell
- Walgreens Boots Alliance Inc., Nottingham, NG90 5EF, U.K
| | - C O'Connor
- Walgreens Boots Alliance Inc., Nottingham, NG90 5EF, U.K
| | - P Olsen
- Bispebjerg Hospital, Department of Dermatological Research, Copenhagen, 2400, Denmark
| | - K Grys
- King's College London, St John's Institute of Dermatology, London, SE1 9RT, U.K
| | - K A Baczynska
- Public Health England, Centre for Radiation, Chemical and Environmental Hazards, Chilton, Didcot, Oxfordshire, OX11 0RQ, U.K
| | | | - H C Wulf
- Bispebjerg Hospital, Department of Dermatological Research, Copenhagen, 2400, Denmark
| | - A Lesiak
- Medical University of Łódź, Department of Dermatology, Pediatric Dermatology and Dermatological Oncology, Łódź, 90-647, Poland
| | - P A Philipsen
- Bispebjerg Hospital, Department of Dermatological Research, Copenhagen, 2400, Denmark
| |
Collapse
|
29
|
Narbutt J, Philipsen P, Harrison G, Morgan K, Lawrence K, Baczynska K, Grys K, Rogowski‐Tylman M, Olejniczak‐Staruch I, Tewari A, Bell M, O'Connor C, Wulf H, Lesiak A, Young A. Optimal sunscreen use prevents holiday erythema. Br J Dermatol 2019. [DOI: 10.1111/bjd.17556] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/01/2022]
|
30
|
Narbutt J, Philipsen P, Harrison G, Morgan K, Lawrence K, Baczynska K, Grys K, Rogowski‐Tylman M, Olejniczak‐Staruch I, Tewari A, Bell M, O'Connor C, Wulf H, Lesiak A, Young A. 优化防晒霜使用以防止假日红斑. Br J Dermatol 2019. [DOI: 10.1111/bjd.17572] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/27/2022]
|
31
|
Klotzbach P, Abhik S, Hendon HH, Bell M, Lucas C, G Marshall A, Oliver ECJ. On the emerging relationship between the stratospheric Quasi-Biennial oscillation and the Madden-Julian oscillation. Sci Rep 2019; 9:2981. [PMID: 30814656 PMCID: PMC6393487 DOI: 10.1038/s41598-019-40034-6] [Citation(s) in RCA: 33] [Impact Index Per Article: 6.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/05/2018] [Accepted: 02/07/2019] [Indexed: 11/16/2022] Open
Abstract
A strong relationship between the quasi-biennial oscillation (QBO) of equatorial stratospheric winds and the amplitude of the Madden-Julian oscillation (MJO) during the boreal winter has recently been uncovered using observational data from the mid-1970s to the present. When the QBO is in its easterly phase in the lower stratosphere, it favors stronger MJO activity during boreal winter, while the MJO tends to be weaker during the westerly phase of the QBO. Here we show using reconstructed indices of the MJO and QBO back to 1905 that the relationship between enhanced boreal winter MJO activity and the easterly phase of the QBO has only emerged since the early 1980s. The emergence of this relationship coincides with the recent cooling trend in the equatorial lower stratosphere and the warming trend in the equatorial upper troposphere, which appears to have sensitized MJO convective activity to QBO-induced changes in static stability near the tropopause. Climate change is thus suggested to have played a role in promoting coupling between the MJO and the QBO.
Collapse
Affiliation(s)
- P Klotzbach
- Department of Atmospheric Science, Colorado State University, Fort Collins, CO, USA.
| | - S Abhik
- School of Earth, Atmosphere & Environment, Monash University, Clayton, Australia
- Bureau of Meteorology, Melbourne, Australia
| | - H H Hendon
- Bureau of Meteorology, Melbourne, Australia
| | - M Bell
- Department of Atmospheric Science, Colorado State University, Fort Collins, CO, USA
| | - C Lucas
- Bureau of Meteorology, Melbourne, Australia
| | | | - E C J Oliver
- Department of Oceanography, Dalhousie University, Halifax, Nova Scotia, Canada
| |
Collapse
|
32
|
Narbutt J, Philipsen PA, Harrison GI, Morgan KA, Lawrence KP, Baczynska KA, Grys K, Rogowski-Tylman M, Olejniczak-Staruch I, Tewari A, Bell M, O'Connor C, Wulf HC, Lesiak A, Young AR. Sunscreen applied at ≥ 2 mg cm -2 during a sunny holiday prevents erythema, a biomarker of ultraviolet radiation-induced DNA damage and suppression of acquired immunity. Br J Dermatol 2018; 180:604-614. [PMID: 30307614 DOI: 10.1111/bjd.17277] [Citation(s) in RCA: 19] [Impact Index Per Article: 3.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 10/08/2018] [Indexed: 01/15/2023]
Abstract
BACKGROUND Sun protection factor (SPF) is assessed with sunscreen applied at 2 mg cm-2 . People typically apply around 0·8 mg cm-2 and use sunscreen daily for holidays. Such use results in erythema, which is a risk factor for skin cancer. OBJECTIVES To determine (i) whether typical sunscreen use resulted in erythema, epidermal DNA damage and photoimmunosuppression during a sunny holiday, (ii) whether optimal sunscreen use inhibited erythema and (iii) whether erythema is a biomarker for photoimmunosuppression in a laboratory study. METHODS Holidaymakers (n = 22) spent a week in Tenerife (very high ultraviolet index) using their own sunscreens without instruction (typical sunscreen use). Others (n = 40) were given SPF 15 sunscreens with instructions on how to achieve the labelled SPF (sunscreen intervention). Personal ultraviolet radiation (UVR) exposure was monitored electronically as the standard erythemal dose (SED) and erythema was quantified. Epidermal cyclobutane pyrimidine dimers (CPDs) were determined by immunostaining, and immunosuppression was assessed by contact hypersensitivity (CHS) response. RESULTS There was no difference between personal UVR exposure in the typical sunscreen use and sunscreen intervention groups (P = 0·08). The former had daily erythema on five UVR-exposed body sites, increased CPDs (P < 0·001) and complete CHS suppression (20 of 22). In comparison, erythema was virtually absent (P < 0·001) when sunscreens were used at ≥ 2 mg cm-2 . A laboratory study showed that 3 SED from three very different spectra suppressed CHS by around ~50%. CONCLUSIONS Optimal sunscreen use prevents erythema during a sunny holiday. Erythema predicts suppression of CHS (implying a shared action spectrum). Given that erythema and CPDs share action spectra, the data strongly suggest that optimal sunscreen use will also reduce CPD formation and UVR-induced immunosuppression.
Collapse
Affiliation(s)
- J Narbutt
- Department of Dermatology, Pediatric Dermatology and Dermatological Oncology, Medical University of Łódź, 90-647, Łódź, Poland
| | - P A Philipsen
- University of Copenhagen, Bispebjerg Hospital, Department of Dermatological Research, Copenhagen, 2400, Denmark
| | - G I Harrison
- King's College London, St John's Institute of Dermatology, London, SE1 9RT, U.K
| | - K A Morgan
- King's College London, St John's Institute of Dermatology, London, SE1 9RT, U.K
| | - K P Lawrence
- King's College London, St John's Institute of Dermatology, London, SE1 9RT, U.K
| | - K A Baczynska
- Public Health England, Centre for Radiation, Chemical and Environmental Hazards, Chilton, Didcot, OX11 0RQ, U.K
| | - K Grys
- King's College London, St John's Institute of Dermatology, London, SE1 9RT, U.K
| | | | - I Olejniczak-Staruch
- Dermoklinika Centrum Medyczne, Łódź, 90-436, Poland.,Department of Dermatology and Venereology, Medical University of Łódź, 90-647, Łódź, Poland
| | - A Tewari
- King's College London, St John's Institute of Dermatology, London, SE1 9RT, U.K
| | - M Bell
- Walgreens Boots Alliance Inc., Nottingham, NG90 5EF, U.K
| | - C O'Connor
- Walgreens Boots Alliance Inc., Nottingham, NG90 5EF, U.K
| | - H C Wulf
- University of Copenhagen, Bispebjerg Hospital, Department of Dermatological Research, Copenhagen, 2400, Denmark
| | - A Lesiak
- Department of Dermatology, Pediatric Dermatology and Dermatological Oncology, Medical University of Łódź, 90-647, Łódź, Poland
| | - A R Young
- King's College London, St John's Institute of Dermatology, London, SE1 9RT, U.K
| |
Collapse
|
33
|
Joly-Tonetti N, Wibawa J, Bell M, Tobin D. 人皮肤表皮中黑色素分布依据. Br J Dermatol 2018. [DOI: 10.1111/bjd.17234] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
34
|
Joly-Tonetti N, Wibawa J, Bell M, Tobin D. Basis of melanin distribution in the human skin epidermis. Br J Dermatol 2018. [DOI: 10.1111/bjd.17220] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
|
35
|
Joly-Tonetti N, Wibawa JID, Bell M, Tobin DJ. An explanation for the mysterious distribution of melanin in human skin: a rare example of asymmetric (melanin) organelle distribution during mitosis of basal layer progenitor keratinocytes. Br J Dermatol 2018; 179:1115-1126. [PMID: 29956303 DOI: 10.1111/bjd.16926] [Citation(s) in RCA: 14] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 05/28/2018] [Indexed: 12/30/2022]
Abstract
BACKGROUND Melanin is synthesized by melanocytes in the basal layer of the epidermis. When transferred to surrounding keratinocytes melanin is the key ultraviolet radiation-protective biopolymer responsible for skin pigmentation. Most melanin is observable in the proliferative basal layer of the epidermis and only sparsely distributed in the stratifying/differentiating epidermis. The latter has been explained as 'melanin degradation' in suprabasal layers. OBJECTIVES To re-evaluate the currently accepted basis for melanin distribution in human epidermis and to discover whether this pattern is altered after a regenerative stimulus. METHODS Normal epidermis of adult human skin, at rest and after tape-stripping, was analysed by a range of (immuno)histochemical and high-resolution microscopy techniques. In vitro models of melanin granule uptake by human keratinocytes were attempted. RESULTS We propose a different fate for melanin in the human epidermis. Our evidence indicates that the bulk of melanin is inherited only by the nondifferentiating daughter cell postmitosis in progenitor keratinocytes via asymmetric organelle inheritance. Moreover, this preferred pattern of melanin distribution can switch to a symmetric or equal daughter cell inheritance mode under conditions of stress, including regeneration. CONCLUSIONS In this preliminary report, we provide a plausible and histologically supported explanation for how human skin pigmentation is efficiently organized in the epidermis. Steady-state epidermis pigmentation may involve much less redox-sensitive melanogenesis than previously thought, and at least some premade melanin may be available for reuse. The epidermal melanin unit may be an excellent example with which to study organelle distribution via asymmetric or symmetric inheritance in response to microenvironment and tissue demands.
Collapse
Affiliation(s)
- N Joly-Tonetti
- Centre for Skin Sciences, Faculty of Life Sciences, University of Bradford, Bradford, U.K
| | | | - M Bell
- Walgreens Boots Alliance, Nottingham, U.K
| | - D J Tobin
- Centre for Skin Sciences, Faculty of Life Sciences, University of Bradford, Bradford, U.K
| |
Collapse
|
36
|
Haufe E, Abraham S, Heratizadeh A, Harder I, Zink A, Weisshaar E, Kleinheinz A, von Kiedrowski R, Worm M, Bell M, Wollenberg A, Neubert K, Staubach-Renz P, Hilgers M, Bieber T, Fell I, Homey B, Effendy I, Mempel M, Schäkel K, Beissert S, Weidinger S, Werfel T, Schmitt J. Verminderte berufliche Leistungsfähigkeit und Lebensqualität bei Patienten mit moderater bis schwerer Neurodermitis. Hautarzt 2018; 69:815-824. [DOI: 10.1007/s00105-018-4261-z] [Citation(s) in RCA: 14] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/28/2022]
|
37
|
Chadwick DR, Cardenas LM, Dhanoa MS, Donovan N, Misselbrook T, Williams JR, Thorman RE, McGeough KL, Watson CJ, Bell M, Anthony SG, Rees RM. The contribution of cattle urine and dung to nitrous oxide emissions: Quantification of country specific emission factors and implications for national inventories. Sci Total Environ 2018; 635:607-617. [PMID: 29679833 PMCID: PMC6024564 DOI: 10.1016/j.scitotenv.2018.04.152] [Citation(s) in RCA: 50] [Impact Index Per Article: 8.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 03/12/2018] [Revised: 04/10/2018] [Accepted: 04/10/2018] [Indexed: 05/27/2023]
Abstract
Urine patches and dung pats from grazing livestock create hotspots for production and emission of the greenhouse gas, nitrous oxide (N2O), and represent a large proportion of total N2O emissions in many national agricultural greenhouse gas inventories. As such, there is much interest in developing country specific N2O emission factors (EFs) for excretal nitrogen (EF3, pasture, range and paddock) deposited during gazing. The aims of this study were to generate separate N2O emissions data for cattle derived urine and dung, to provide an evidence base for the generation of a country specific EF for the UK from this nitrogen source. The experiments were also designed to determine the effects of site and timing of application on emissions, and the efficacy of the nitrification inhibitor, dicyandiamide (DCD) on N2O losses. This co-ordinated set of 15 plot-scale, year-long field experiments using static chambers was conducted at five grassland sites, typical of the soil and climatic zones of grazed grassland in the UK. We show that the average urine and dung N2O EFs were 0.69% and 0.19%, respectively, resulting in a combined excretal N2O EF (EF3), of 0.49%, which is <25% of the IPCC default EF3 for excretal returns from grazing cattle. Regression analysis suggests that urine N2O EFs were controlled more by composition than was the case for dung, whilst dung N2O EFs were more related to soil and environmental factors. The urine N2O EF was significantly greater from the site in SW England, and significantly greater from the early grazing season urine application than later applications. Dycandiamide reduced the N2O EF from urine patches by an average of 46%. The significantly lower excretal EF3 than the IPCC default has implications for the UK's national inventory and for subsequent carbon footprinting of UK ruminant livestock products.
Collapse
Affiliation(s)
- D R Chadwick
- School of Environment, Natural Resources and Geography, Bangor University, Bangor LL57 2UW, UK.
| | - L M Cardenas
- Rothamsted Research, North Wyke, Devon EX20 2SB, UK
| | - M S Dhanoa
- Rothamsted Research, North Wyke, Devon EX20 2SB, UK
| | - N Donovan
- Rothamsted Research, North Wyke, Devon EX20 2SB, UK
| | | | - J R Williams
- ADAS Boxworth, Battlegate Rd., Cambridge CB23 4NN, UK
| | - R E Thorman
- ADAS Boxworth, Battlegate Rd., Cambridge CB23 4NN, UK
| | - K L McGeough
- Agri-Food and Biosciences Institute, 18a, Newforge Lane, BT9 5PX, Belfast, UK
| | - C J Watson
- Agri-Food and Biosciences Institute, 18a, Newforge Lane, BT9 5PX, Belfast, UK
| | - M Bell
- Scotland's Rural College (SRUC), West Mains Road, Edinburgh EH9 3JG, UK
| | - S G Anthony
- ADAS Wolverhampton, Titan 1 offices, Coxwell Avenue, Wolverhampton Science Park, Wolverhampton WV10 9RT, UK
| | - R M Rees
- Scotland's Rural College (SRUC), West Mains Road, Edinburgh EH9 3JG, UK
| |
Collapse
|
38
|
Zhou H, Slominski R, Dave P, Wright W, Seymour L, Bell M, Spandau D, Turner M. LB1566 Investigation of inflammatory response mediators in ex vivo skin culture. J Invest Dermatol 2018. [DOI: 10.1016/j.jid.2018.06.102] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/28/2022]
|
39
|
Diffey BL, O'Connor C, Marlow I, Bell M, O'Mahony MM. A theoretical and experimental study of the temporal reduction in UV protection provided by a facial day cream. Int J Cosmet Sci 2018; 40:401-407. [DOI: 10.1111/ics.12480] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/23/2018] [Accepted: 07/04/2018] [Indexed: 11/29/2022]
Affiliation(s)
- B. L. Diffey
- Dermatological Sciences; Newcastle University; Newcastle Upon Tyne NE2 4HH UK
| | - C. O'Connor
- Walgreens Boots Alliance; Thane Road Nottingham NG90 1BS UK
| | - I. Marlow
- Walgreens Boots Alliance; Thane Road Nottingham NG90 1BS UK
| | - M. Bell
- Walgreens Boots Alliance; Thane Road Nottingham NG90 1BS UK
| | - M. M. O'Mahony
- Walgreens Boots Alliance; Thane Road Nottingham NG90 1BS UK
| |
Collapse
|
40
|
Walker EMK, Bell M, Cook TM, Grocott MPW, Moonesinghe SR. Patient reported outcome of adult perioperative anaesthesia in the United Kingdom: a cross-sectional observational study. Br J Anaesth 2018; 117:758-766. [PMID: 27956674 DOI: 10.1093/bja/aew381] [Citation(s) in RCA: 113] [Impact Index Per Article: 18.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 10/21/2016] [Indexed: 12/22/2022] Open
Abstract
BACKGROUND Understanding the patient perspective on healthcare is central to the evaluation of quality. This study measured selected patient-reported outcomes after anaesthesia in order to identify targets for research and quality improvement. METHODS This cross-sectional observational study in UK National Health Service hospitals, recruited adults undergoing non-obstetric surgery requiring anaesthesia care over a 48 h period. Within 24 h of surgery, patients completed the Bauer questionnaire (measuring postoperative discomfort and satisfaction with anaesthesia care), and a modified Brice questionnaire to elicit symptoms suggestive of accidental awareness during general anaesthesia (AAGA). Patient, procedural and pharmacological data were recorded to enable exploration of risk factors for these poor outcomes. RESULTS 257 hospitals in 171 NHS Trusts participated (97% of eligible organisations). Baseline characteristics were collected on 16,222 patients; 15,040 (93%) completed postoperative questionnaires. Anxiety was most frequently cited as the worst aspect of the perioperative experience. Thirty-five per cent of patients reported severe discomfort in at least one domain: thirst (18.5%; 95% CI 17.8-19.1), surgical pain (11.0%; 10.5-11.5) and drowsiness (10.1%; 9.6-10.5) were most common. Despite this, only 5% reported dissatisfaction with any aspect of anaesthesia-related care. Regional anaesthesia was associated with a reduced burden of side-effects. The incidence of reported AAGA was one in 800 general anaesthetics (0.12%) CONCLUSIONS Anxiety and discomfort after surgery are common; despite this, satisfaction with anaesthesia care in the UK is high. The inconsistent relationship between patient-reported outcome, patient experience and patient satisfaction supports using all three of these domains to provide a comprehensive assessment of the quality of anaesthesia care.
Collapse
Affiliation(s)
- E M K Walker
- National Institute of Academic Anaesthesia Health Services Research Centre, Royal College of Anaesthetists, London, WC1R 4SG, UK
| | - M Bell
- Royal College of Anaesthetists, London, WC1R 4SG, UK
| | - T M Cook
- Royal United Hospital NHS Foundation Trust Bath, BA1 3NG, UK
| | - M P W Grocott
- Faculty of Medicine, University of Southampton, Southampton, SO17 1BJ, UK
| | - S R Moonesinghe
- National Institute of Academic Anaesthesia Health Services Research Centre, Royal College of Anaesthetists, London, WC1R 4SG, UK, and UCL/UCLH Surgical Outcomes Research Centre, Department of Anaesthetics and UCL Centre for Anaesthesia, University College Hospital, London, NW1 2BU, UK
| | | | | |
Collapse
|
41
|
McDonnell TC, Belyazid S, Sullivan TJ, Bell M, Clark C, Blett T, Evans T, Cass W, Hyduke A, Sverdrup H. Vegetation dynamics associated with changes in atmospheric nitrogen deposition and climate in hardwood forests of Shenandoah and Great Smoky Mountains National Parks, USA. Environ Pollut 2018; 237:662-674. [PMID: 29549857 DOI: 10.1016/j.envpol.2018.01.112] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 08/15/2017] [Revised: 01/30/2018] [Accepted: 01/31/2018] [Indexed: 06/08/2023]
Abstract
Ecological effects of atmospheric nitrogen (N) and sulfur (S) deposition on two hardwood forest sites in the eastern United States were simulated in the context of a changing climate using the dynamic coupled biogeochemical/ecological model chain ForSAFE-Veg. The sites are a mixed oak forest in Shenandoah National Park, Virginia (Piney River) and a mixed oak-sugar maple forest in Great Smoky Mountains National Park, Tennessee (Cosby Creek). The sites have received relatively high levels of both S and N deposition and the climate has warmed over the past half century or longer. The model was used to evaluate the composition of the understory plant communities, the alignment between plant species niche preferences and ambient conditions, and estimate changes in relative species abundances as reflected by plant cover under various scenarios of future atmospheric N and S deposition and climate change. The main driver of ecological effects was soil solution N concentration. Results of this research suggested that future climate change might compromise the capacity for the forests to sustain habitat suitability. However, vegetation results should be considered preliminary until further model validation can be performed. With expected future climate change, preliminary estimates suggest that sustained future N deposition above 7.4 and 5.0 kg N/ha/yr is expected to decrease contemporary habitat suitability for indicator plant species located at Piney River and Cosby Creek, respectively.
Collapse
Affiliation(s)
- T C McDonnell
- E&S Environmental Chemistry, Inc., PO Box 609, Corvallis, OR 97339, United States.
| | - S Belyazid
- Belyazid Consulting & Communication AB, Hyby Kyrkoväg 170, SE-233 76 Klågerup, Sweden.
| | - T J Sullivan
- E&S Environmental Chemistry, Inc., PO Box 609, Corvallis, OR 97339, United States.
| | - M Bell
- National Park Service-Air Resources Division, PO Box 25287, Denver, CO 80225-0287, United States.
| | - C Clark
- US EPA, Office of Research and Development, National Center for Environmental Assessment, Washington, DC 20460, United States.
| | - T Blett
- National Park Service-Air Resources Division, PO Box 25287, Denver, CO 80225-0287, United States.
| | - T Evans
- National Park Service - Great Smoky Mountains National Park, 107 Park Headquarters Rd, Gatlinburg, TN 37738, United States.
| | - W Cass
- Shenandoah National Park, 3655 US Highway 211 E, Luray, VA 22835-4702, United States.
| | - A Hyduke
- Shenandoah National Park, 3655 US Highway 211 E, Luray, VA 22835-4702, United States.
| | - H Sverdrup
- School of Engineering and Natural Sciences, University of Iceland, Sæmundargötu 2, 101 Reykjavík, Iceland.
| |
Collapse
|
42
|
Vanlierde A, Soyeurt H, Gengler N, Colinet FG, Froidmont E, Kreuzer M, Grandl F, Bell M, Lund P, Olijhoek DW, Eugène M, Martin C, Kuhla B, Dehareng F. Short communication: Development of an equation for estimating methane emissions of dairy cows from milk Fourier transform mid-infrared spectra by using reference data obtained exclusively from respiration chambers. J Dairy Sci 2018; 101:7618-7624. [PMID: 29753478 DOI: 10.3168/jds.2018-14472] [Citation(s) in RCA: 30] [Impact Index Per Article: 5.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/19/2018] [Accepted: 04/01/2018] [Indexed: 11/19/2022]
Abstract
Evaluation and mitigation of enteric methane (CH4) emissions from ruminant livestock, in particular from dairy cows, have acquired global importance for sustainable, climate-smart cattle production. Based on CH4 reference measurements obtained with the SF6 tracer technique to determine ruminal CH4 production, a current equation permits evaluation of individual daily CH4 emissions of dairy cows based on milk Fourier transform mid-infrared (FT-MIR) spectra. However, the respiration chamber (RC) technique is considered to be more accurate than SF6 to measure CH4 production from cattle. This study aimed to develop an equation that allows estimating CH4 emissions of lactating cows recorded in an RC from corresponding milk FT-MIR spectra and to challenge its robustness and relevance through validation processes and its application on a milk spectral database. This would permit confirming the conclusions drawn with the existing equation based on SF6 reference measurements regarding the potential to estimate daily CH4 emissions of dairy cows from milk FT-MIR spectra. A total of 584 RC reference CH4 measurements (mean ± standard deviation of 400 ± 72 g of CH4/d) and corresponding standardized milk mid-infrared spectra were obtained from 148 individual lactating cows between 7 and 321 d in milk in 5 European countries (Germany, Switzerland, Denmark, France, and Northern Ireland). The developed equation based on RC measurements showed calibration and cross-validation coefficients of determination of 0.65 and 0.57, respectively, which is lower than those obtained earlier by the equation based on 532 SF6 measurements (0.74 and 0.70, respectively). This means that the RC-based model is unable to explain the variability observed in the corresponding reference data as well as the SF6-based model. The standard errors of calibration and cross-validation were lower for the RC model (43 and 47 g/d vs. 66 and 70 g/d for the SF6 version, respectively), indicating that the model based on RC data was closer to actual values. The root mean squared error (RMSE) of calibration of 42 g/d represents only 10% of the overall daily CH4 production, which is 23 g/d lower than the RMSE for the SF6-based equation. During the external validation step an RMSE of 62 g/d was observed. When the RC equation was applied to a standardized spectral database of milk recordings collected in the Walloon region of Belgium between January 2012 and December 2017 (1,515,137 spectra from 132,658 lactating cows in 1,176 different herds), an average ± standard deviation of 446 ± 51 g of CH4/d was estimated, which is consistent with the range of the values measured using both RC and SF6 techniques. This study confirmed that milk FT-MIR spectra could be used as a potential proxy to estimate daily CH4 emissions from dairy cows provided that the variability to predict is covered by the model.
Collapse
Affiliation(s)
- A Vanlierde
- Walloon Agricultural Research Centre, Valorization of Agricultural Products, 5030 Gembloux, Belgium
| | - H Soyeurt
- Gembloux Agro-Bio Tech, University of Liège, Agrobiochem Department and Research and Teaching Centre (TERRA), 5030 Gembloux, Belgium
| | - N Gengler
- Gembloux Agro-Bio Tech, University of Liège, Agrobiochem Department and Research and Teaching Centre (TERRA), 5030 Gembloux, Belgium
| | - F G Colinet
- Gembloux Agro-Bio Tech, University of Liège, Agrobiochem Department and Research and Teaching Centre (TERRA), 5030 Gembloux, Belgium
| | - E Froidmont
- Walloon Agricultural Research Centre, Production and Sectors Department, 5030 Gembloux, Belgium
| | - M Kreuzer
- ETH Zürich, Institute of Agricultural Sciences, 8092 Zürich, Switzerland
| | - F Grandl
- Qualitas AG, 6300 Zug, Switzerland
| | - M Bell
- Agri-Food and Biosciences Institute, Large Park, Hillsborough, BT26 6DR, United Kingdom
| | - P Lund
- Department of Animal Science, AU Foulum, Aarhus University, 8830 Tjele, Denmark
| | - D W Olijhoek
- Department of Animal Science, AU Foulum, Aarhus University, 8830 Tjele, Denmark
| | - M Eugène
- UMR Herbivores, INRA, VetAgro Sup, Université Clermont Auvergne, 63122 Saint-Genès-Champanelle, France
| | - C Martin
- UMR Herbivores, INRA, VetAgro Sup, Université Clermont Auvergne, 63122 Saint-Genès-Champanelle, France
| | - B Kuhla
- Leibniz Institute for Farm Animal Biology (FBN), Institute of Nutritional Physiology, 18196 Dummerstorf, Germany.
| | - F Dehareng
- Walloon Agricultural Research Centre, Valorization of Agricultural Products, 5030 Gembloux, Belgium
| |
Collapse
|
43
|
Mårtensson J, Vaara ST, Pettilä V, Ala-Kokko T, Karlsson S, Inkinen O, Uusaro A, Larsson A, Bell M. Assessment of plasma endostatin to predict acute kidney injury in critically ill patients. Acta Anaesthesiol Scand 2017; 61:1286-1295. [PMID: 28857121 DOI: 10.1111/aas.12988] [Citation(s) in RCA: 12] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/22/2017] [Revised: 06/12/2017] [Accepted: 08/13/2017] [Indexed: 12/11/2022]
Abstract
BACKGROUND We evaluated whether plasma endostatin predicts acute kidney injury (AKI), need for renal replacement therapy (RRT), or death. METHODS Prospective, observational, multicenter study from 1 September 2011 to 1 February 2012 with data from 17 intensive care units (ICUs) in Finland. RESULTS A total of 1112 patients were analyzed. We measured plasma endostatin within 2 h of ICU admission. Early AKI (KDIGO stage within 12 h of ICU admission) was found in 20% of the cohort, and 18% developed late AKI (KDIGO criteria > 12 h from ICU admission). Median (IQR) admission endostatin was higher in the early AKI group, 29 (19.1, 41.9) ng/ml as compared to 22.4 (16.1, 30.1) ng/ml for the late AKI group, and 18 (14.0, 23.6) ng/ml for non-AKI patients (P < 0.001). Endostatin level increased with increasing KDIGO stage. Significantly higher endostatin levels were found in patients with sepsis as compared to those without. Predictive properties for AKI, RRT, and mortality were low with corresponding areas under the receiver operating characteristic curve (AUC) of 0.62, 0.67, and 0.59. Sensitivity analyses among patients with chronic kidney disease or sepsis did not improve the predictive ability of endostatin. Adding endostatin to a clinical AKI prediction model (illness severity score, urine output, and age) insignificantly changed the AUC from 0.67 to 0.70 (P = 0.14). CONCLUSIONS Endostatin increases with AKI severity but has limited value as a predictor of AKI, RRT and 90-day mortality in patients admitted to ICU. Moreover, endostatin does not improve AKI risk prediction when added to a clinical risk model.
Collapse
Affiliation(s)
- J. Mårtensson
- Perioperative Medicine and Intensive Care; Department of Physiology and Pharmacology; Karolinska Institutet; Karolinska University Hospital; Stockholm Sweden
- Department of Intensive Care; Austin Hospital; Heidelberg Vic. Australia
| | - S. T. Vaara
- Department of Intensive Care; Austin Hospital; Heidelberg Vic. Australia
- Intensive Care Medicine; Department of Anesthesiology; Intensive Care and Pain Medicine; Helsinki University Hospital; University of Helsinki; Helsinki Finland
| | - V. Pettilä
- Intensive Care Medicine; Department of Anesthesiology; Intensive Care and Pain Medicine; Helsinki University Hospital; University of Helsinki; Helsinki Finland
| | - T. Ala-Kokko
- Medical Research Center; Research Group of Surgery, Anesthesia and Intensive Care; University of Oulu; Oulu Finland
- Department of Anesthesiology; Division of Intensive Care; Oulu University Hospital; Oulu Finland
| | - S. Karlsson
- Intensive Care Medicine; Tampere University Hospital; University of Tampere; Tampere Finland
| | - O. Inkinen
- Intensive Care; Turku University Hospital; Turku Finland
| | - A. Uusaro
- Intensive Care; Kuopio University Hospital; Kuopio Finland
| | - A. Larsson
- Department of Medical Sciences, Clinical Chemistry; Uppsala University; Uppsala Sweden
| | - M. Bell
- Perioperative Medicine and Intensive Care; Department of Physiology and Pharmacology; Karolinska Institutet; Karolinska University Hospital; Stockholm Sweden
| |
Collapse
|
44
|
McVeigh TP, Mulligan RJ, McVeigh UM, Owens PW, Miller N, Bell M, Sebag F, Guerin C, Quill DS, Weidhaas JB, Kerin MJ, Lowery AJ. Investigating the association of rs2910164 with cancer predisposition in an Irish cohort. Endocr Connect 2017; 6:614-624. [PMID: 28899898 PMCID: PMC5640569 DOI: 10.1530/ec-17-0196] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 08/24/2017] [Accepted: 09/12/2017] [Indexed: 01/05/2023]
Abstract
INTRODUCTION MicroRNAs (miRNAs) are small noncoding RNA molecules that exert post-transcriptional effects on gene expression by binding with cis-regulatory regions in target messenger RNA (mRNA). Polymorphisms in genes encoding miRNAs or in miRNA-mRNA binding sites confer deleterious epigenetic effects on cancer risk. miR-146a has a role in inflammation and may have a role as a tumour suppressor. The polymorphism rs2910164 in the MIR146A gene encoding pre-miR-146a has been implicated in several inflammatory pathologies, including cancers of the breast and thyroid, although evidence for the associations has been conflicting in different populations. We aimed to further investigate the association of this variant with these two cancers in an Irish cohort. METHODS The study group comprised patients with breast cancer (BC), patients with differentiated thyroid cancer (DTC) and unaffected controls. Germline DNA was extracted from blood or from saliva collected using the DNA Genotek Oragene 575 collection kit, using crystallisation precipitation, and genotyped using TaqMan-based PCR. Data were analysed using SPSS, v22. RESULTS The total study group included 1516 participants. This comprised 1386 Irish participants; 724 unaffected individuals (controls), 523 patients with breast cancer (BC), 136 patients with differentiated thyroid cancer (DTC) and three patients with dual primary breast and thyroid cancer. An additional cohort of 130 patients with DTC from the South of France was also genotyped for the variant. The variant was detected with a minor allele frequency (MAF) of 0.19 in controls, 0.22 in BC and 0.27 and 0.26 in DTC cases from Ireland and France, respectively. The variant was not significantly associated with BC (per allele odds ratio = 1.20 (0.98-1.46), P = 0.07), but was associated with DTC in Irish patients (per allele OR = 1.59 (1.18-2.14), P = 0.002). CONCLUSION The rs2910164 variant in MIR146A is significantly associated with DTC, but is not significantly associated with BC in this cohort.
Collapse
Affiliation(s)
- T P McVeigh
- Discipline of SurgeryLambe Institute for Translational Research, School of Medicine, NUI Galway, Galway, Ireland
| | - R J Mulligan
- Discipline of SurgeryLambe Institute for Translational Research, School of Medicine, NUI Galway, Galway, Ireland
| | - U M McVeigh
- Discipline of SurgeryLambe Institute for Translational Research, School of Medicine, NUI Galway, Galway, Ireland
| | - P W Owens
- Discipline of SurgeryLambe Institute for Translational Research, School of Medicine, NUI Galway, Galway, Ireland
| | - N Miller
- Discipline of SurgeryLambe Institute for Translational Research, School of Medicine, NUI Galway, Galway, Ireland
| | - M Bell
- Department of EndocrinologySchool of Medicine, NUI Galway, Galway, Ireland
| | - F Sebag
- Department of Endocrine Surgery Centre hospitalo-universitaire de La ConceptionAssistance Publique Hôpitaux de Marseille, Marseille, France
- Aix-Marseille UniversitéFaculté de Médecine, Marseille, France
| | - C Guerin
- Department of Endocrine Surgery Centre hospitalo-universitaire de La ConceptionAssistance Publique Hôpitaux de Marseille, Marseille, France
- Aix-Marseille UniversitéFaculté de Médecine, Marseille, France
| | - D S Quill
- Discipline of SurgeryLambe Institute for Translational Research, School of Medicine, NUI Galway, Galway, Ireland
| | - J B Weidhaas
- David Geffen School of MedicineUniversity of California, Los Angeles, USA
| | - M J Kerin
- Discipline of SurgeryLambe Institute for Translational Research, School of Medicine, NUI Galway, Galway, Ireland
| | - A J Lowery
- Discipline of SurgeryLambe Institute for Translational Research, School of Medicine, NUI Galway, Galway, Ireland
| |
Collapse
|
45
|
Wofford JA, Zollers B, Rhodes L, Bell M, Heinen E. Evaluation of the safety of daily administration of capromorelin in cats. J Vet Pharmacol Ther 2017; 41:324-333. [DOI: 10.1111/jvp.12459] [Citation(s) in RCA: 11] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/08/2017] [Accepted: 09/03/2017] [Indexed: 12/12/2022]
Affiliation(s)
| | - B. Zollers
- Aratana Therapeutics, Inc.; Leawood KS USA
| | - L. Rhodes
- Aratana Therapeutics, Inc.; Leawood KS USA
| | - M. Bell
- ClinData Services, Inc.; Fort Collins CO USA
| | - E. Heinen
- Aratana Therapeutics, Inc.; Leawood KS USA
| |
Collapse
|
46
|
Joly-Tonetti N, Wibawa J, Bell M, Tobin D. 618 Asymmetric melanin distribution during the mitosis of human skin progenitor keratinocytes. J Invest Dermatol 2017. [DOI: 10.1016/j.jid.2017.07.294] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
47
|
Pratt C, Ukogu C, Colby A, Gounko D, Lee J, Bell M, Daneyko M, Copperman A, Davis J. Efficacy of patient self-administered recombinant human chorionic gonadotropin (RHCG) is comparable to nurse administred RHCG in ovulation induction cycles. Fertil Steril 2017. [DOI: 10.1016/j.fertnstert.2017.07.308] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/24/2022]
|
48
|
Levin I, Sekhon L, Nazem T, Lee J, Copperman N, Bell M, Daneyko M, Copperman A. How often do patients undergoing IVF with preimplantation genetic screening have an embryo sex preference? Fertil Steril 2017. [DOI: 10.1016/j.fertnstert.2017.07.829] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|
49
|
Hibbert SA, Costello P, O'Connor C, Bell M, Griffiths CEM, Watson REB, Sherratt MJ. A new in vitro assay to test UVR protection of dermal extracellular matrix components by a flat spectrum sunscreen. J Photochem Photobiol B 2017; 175:58-64. [PMID: 28846936 DOI: 10.1016/j.jphotobiol.2017.08.020] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 03/30/2017] [Revised: 07/10/2017] [Accepted: 08/14/2017] [Indexed: 01/08/2023]
Abstract
The efficacy of topical sunscreens is currently assessed by crude, costly and time consuming in vivo assays. We have previously demonstrated that components of the dermal extracellular matrix (ECM), rich in UV-absorbing amino acids, are susceptible to damage by solar simulated radiation (SSR) in vitro. Here we developed an in vitro method to test the ability of sunscreens to protect fibrillin-rich microfibrils (FRM) and fibronectin, key components of the dermal ECM from UV-induced damage. Solutions of FRM or fibronectin were irradiated without protection, in the presence of a vehicle or a commercially-available flat-spectrum sunscreen. The effect of SSR on molecular structure was determined by atomic force microscopy (FRM) and SDS-PAGE (fibronectin). Following irradiation, FRM periodicity became bi-modally distributed (peaks: 40nm & 59nm) compared to the unimodal distribution in unexposed controls (peak: 50nm). Irradiation in the presence of flat-spectrum sunscreen protected against this change, maintaining the unimodal distribution. SSR induced significant aggregation of fibronectin (p=0.005), which was abrogated by sunscreen. These results demonstrate that this in vitro assay system is sufficiently sensitive to act as an initial/additional screen of sunscreen efficacy. We conclude that sunscreen can reduce UV-mediated damage of key dermal ECM in vitro and thereby prevent remodelling associated with photoageing.
Collapse
Affiliation(s)
- S A Hibbert
- Division of Cell Matrix Biology & Regenerative Medicine, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester Academic Health Science Centre, Manchester, UK
| | - P Costello
- Centre for Dermatology Research, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, UK; NIHR Manchester Biomedical Research Centre, Central Manchester University Hospitals NHS Foundation Trust, Manchester Academic Health Science Centre, UK; Salford Royal NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, UK
| | - C O'Connor
- Walgreens Boots Alliance, Thane Road, Nottingham, UK
| | - M Bell
- Walgreens Boots Alliance, Thane Road, Nottingham, UK
| | - C E M Griffiths
- Centre for Dermatology Research, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, UK; NIHR Manchester Biomedical Research Centre, Central Manchester University Hospitals NHS Foundation Trust, Manchester Academic Health Science Centre, UK; Salford Royal NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, UK
| | - R E B Watson
- Centre for Dermatology Research, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, UK; NIHR Manchester Biomedical Research Centre, Central Manchester University Hospitals NHS Foundation Trust, Manchester Academic Health Science Centre, UK; Salford Royal NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, UK.
| | - M J Sherratt
- Division of Cell Matrix Biology & Regenerative Medicine, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester Academic Health Science Centre, Manchester, UK
| |
Collapse
|
50
|
Hasan J, Bell M, Kushinga G, Nicholas N, Delahaye M, Kerby J, Baptista R, Ward S. A semi-automated cost-efficient process for the closed expansion and harvest of pluripotent stem cells using a hollow fibre bioreactor and continuous centrifugation. Cytotherapy 2017. [DOI: 10.1016/j.jcyt.2017.02.245] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/19/2022]
|